310 results on '"Pålsson, Erik"'
Search Results
2. Cardiometabolic risk indicators in individuals with bipolar disorders: a replication study
3. Dissecting the impact of complement component 4A in bipolar disorder
4. Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorder
5. Altered brain dopamine metabolism is a trait marker for bipolar disorder
6. Alterations in the Serum Proteome Following Electroconvulsive Therapy for a Major Depressive Episode: A Longitudinal Multicenter Study
7. Proteins associated with future suicide attempts in bipolar disorder: A large-scale biomarker discovery study
8. Association of Occupational Dysfunction and Hospital Admissions With Different Polygenic Profiles in Bipolar Disorder
9. Cohort Profile: The St. Göran Bipolar Project
10. A serum proteomic study of two case-control cohorts identifies novel biomarkers for bipolar disorder
11. Cerebrospinal fluid proteomics targeted for central nervous system processes in bipolar disorder
12. Serum profiling of anorexia nervosa: A 1H NMR-based metabolomics study
13. Central levels of tryptophan metabolites in subjects with bipolar disorder
14. Influence of genetic variations in IL1B on brain region volumes in bipolar patients and controls
15. Genome-wide association study of patients with a severe major depressive episode treated with electroconvulsive therapy
16. Dissecting the impact of complement component 4A in bipolar disorder
17. International Consortium on the Genetics of Electroconvulsive Therapy and Severe Depressive Disorders (Gen-ECT-ic)
18. Genomic and drug target evaluation of 90 cardiovascular proteins in 30,931 individuals
19. Regional lithium prescription rates and recurrence in bipolar disorder
20. Polygenic scores for psychiatric disorders associate with year of first bipolar disorder diagnosis: A register-based study between 1972 and 2016
21. Recent Secular Trends of Body Mass Index in Individuals With Bipolar Disorders and in the General Population.
22. Recent Secular Trends of Body Mass Index in Individuals With Bipolar Disorders and in the General Population
23. Executive functioning but not IQ or illness severity predicts occupational status in bipolar disorder
24. Ghrelin activates the mesolimbic dopamine system via nitric oxide associated mechanisms in the ventral tegmental area
25. Blood metabolomics analysis identifies abnormalities in the citric acid cycle, urea cycle, and amino acid metabolism in bipolar disorder
26. Dietary intake, resting energy expenditure, and eating behavior in women with and without polycystic ovary syndrome
27. Additional file 1 of Cardiometabolic risk indicators in individuals with bipolar disorders: a replication study
28. Prospective cohort study of early biosignatures of response to lithium in bipolar-I-disorders: overview of the H2020-funded R-LiNK initiative
29. CSF neuroinflammatory biomarkers in bipolar disorder are associated with cognitive impairment
30. Increased cerebrospinal fluid interleukin-8 in bipolar disorder patients associated with lithium and antipsychotic treatment
31. Markers of glutamate signaling in cerebrospinal fluid and serum from patients with bipolar disorder and healthy controls
32. Cohort profile: the Swedish National Quality Register for bipolar disorder(BipoläR)
33. Alterations in the serum proteome following electroconvulsive therapy for a major depressive episode: a longitudinal multicenter study
34. Time effect on cardiometabolic risk indicators in patients with bipolar disorder: a longitudinal case–control study
35. Effect of CYP2C19 polymorphisms on antidepressant prescription patterns and treatment emergent mania in bipolar disorder
36. Association Between Polygenic Risk Scores and Outcome of ECT
37. T24. NOT ALL BIPOLAR DISORDER OUTCOMES ARE CREATED EQUAL: OCCUPATIONAL DYSFUNCTION AND HOSPITAL ADMISSIONS ASSOCIATE WITH DIFFERENT POLYGENIC LIABILITIES
38. Cerebrospinal fluid monoamine metabolite profiles in bipolar disorder, ADHD, and controls
39. Low neuropeptide Y in cerebrospinal fluid in bipolar patients is associated with previous and prospective suicide attempts
40. The Role of Atypicals With Regard to Weight Gain in Bipolar Disorder Treatment: Response to Mattes.
41. Blood–cerebrospinal fluid barrier dysfunction in patients with bipolar disorder in relation to antipsychotic treatment
42. Abnormality in serum levels of mature brain-derived neurotrophic factor (BDNF) and its precursor proBDNF in mood-stabilized patients with bipolar disorder: A study of two independent cohorts
43. Ghrelin activates the mesolimbic dopamine system via nitric oxide dependent mechanisms in the ventral tegmental area
44. Metabolomics analysis of cerebrospinal fluid suggests citric acid cycle aberrations in bipolar disorder
45. Prefrontal NMDA receptor antagonism reduces impairments in pre-attentive information processing
46. TH21. CEREBROSPINAL FLUID PROTEOMICS TARGETED FOR CENTRAL NERVOUS SYSTEM PROCESSES IN BIPOLAR DISORDER
47. Polymorphisms of dopamine pathway genes NRG1 and LMX1A are associated with cognitive performance in bipolar disorder
48. Monocyte and microglial activation in patients with mood-stabilized bipolar disorder
49. Characterisation of age and polarity at onset in bipolar disorder
50. Additional file 1 of Regional lithium prescription rates and recurrence in bipolar disorder
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.